Cell Type | Species | VPAC1 | VPAC2 | PAC1 | Comments | References |
---|---|---|---|---|---|---|
HMC-1 (mast) | Human | + | + | ND | ↓ Vpr2 mRNA after low PMA stimulation | Groneberg et al., 2003 |
Skin mast cells | Human | ND | + | ND | ↓ VPAC2 protein in atopic dermatitis | Groneberg et al., 2003 |
HC3 (mast) | Mouse | − | + | − | Waschek et al., 1995 | |
Monocytes | Human | + | − | ND | Resting monocytes | Lara-Marquez et al., 2001 |
Monocytes | Human | ND | + | ND | Resting monocytes | Dewit et al., 1998 |
THP-1 (monocytic) | Human | + | −(+) | + | Vpr2 mRNA after LPS stimulation | Delgado and Ganea, 2001b |
Raw 264.7 (macrophage) | Mouse | + | −(+) | + | Vpr2 mRNA after LPS stimulation | Delgado et al., 1998 |
Peritoneal macrophages | Rat | + | ND | ND | Delgado et al., 1996c | |
Peritoneal macrophages | Rat | + | ND | + | Pozo et al., 1997a | |
Osteclasts | Mouse | + | − | + | Ransjo et al., 2000 | |
Bone marrow | Mouse | + | + | + | Ransjo et al., 2000 | |
Osteoblasts | Mouse | −(+) | + | − | Vpr1 mRNA after differentiation | Lundberg et al., 2001 |
Osteoblasts | Human | + | − | − | Togari et al., 1997 | |
Alveolar macrophages | Mouse | + | + | ND | ↑ Vpr1 mRNA after lung inflammation | Kaltreider et al., 1997 |
Alveolar macrophages | Human | ND | + | ND | Groneberg et al., 2001 | |
Granuloma cells | Mouse | + | + | ND | Vpr2 mRNA only in granuloma T cells | Metwali et al., 1996 |
Splenic CD4+ T cells | Mouse | ND | −(+) | ND | Inducible after CD3/anti-IL-4 mAb treatment | Metwali et al., 2000 |
Lymphocytes | Rat | + | ND | ND | Thymus, spleen, and lymph nodes (B and T cells) | Gomariz et al., 1994a |
Thymocytes | Rat | + | ND | ND | CD4+ CD8+; CD4− CD8+; CD4+ CD8− | Delgado et al., 1996b |
Lymphocytes | Mouse | + | − | ND | Spleen B and T lymphocytes | Waschek et al., 1995 |
Thymocytes/splenocytes | Mouse | + | ND | ND | CD4+ and CD8+ T cells; no expression in B cells | Johnson et al., 1996 |
Thymocytes/splenocytes | Mouse | + | −(+) | ND | Vpr2 induced after CD3/PMA treatment | Delgado et al., 1996a |
Thymocytes/splenocytes | Mouse | + | + | ND | Vpr2 mediated differentiation into CD4+ CD8− | Pankhaniya et al., 1998 |
Thymocytes | Human | + | + | ND | Vpr2 mainly expression | Lara-Marquez et al., 2000 |
Intestinal T lymphocytes | Mouse | + | + | ND | Vpr2 only in CD8+ T cells (CD8αβ and CD8αα) | Qian et al., 2001 |
Peripheral lymphocytes | Human | + | + | ND | ↓ Vpr1 after stimulation; low Vpr2 levels | Lara-Marquez et al., 2001 |
Langerhans cells | Mouse | + | + | − | Torii et al., 1997 | |
Microglia | Rat | + | − | + | Vpr2 expression unresponsive to LPS | Kim et al., 2000 |
Microglia | Mouse | + | − | + | Vpr2 expression unresponsive to LPS | Delgado et al., 2002b |
Keratinocytes | Human | + | + | − | ↑ Vpr1 upon serum deprivation | Granoth et al., 2001 |
Keratinocytes | Human | + | − | ND | ↑ Vpr1 by IFNγ, IL-4, TNFα, and VIP | Kakurai et al., 2001 |
Epithelial cells | Thymus | + | ND | ND | Marie et al., 1999 |
ND, not determined in the cited reference.